Kite Pharma, Inc. Available-for-sale Securities
Kite Pharma, Inc. had Available-for-sale Securities of $299.86 million as of 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2017-02-28
- 2016-12-31: Available-for-sale Securities $299.86M.
- 2016-09-30: Available-for-sale Securities $398.37M.
- 2016-06-30: Available-for-sale Securities $434.63M.
- 2016-03-31: Available-for-sale Securities $380.31M.
| Period end | Available-for-sale Securities |
|---|---|
| 2016-12-31 | $299.86M 10-K · filed 2017-02-28 |
| 2016-09-30 | $398.37M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $434.63M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $380.31M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $221.88M 10-K · filed 2017-02-28 |
| 2015-09-30 | $197.57M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $131.15M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $144.61M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $157.74M 10-K · filed 2016-02-29 |
| 2014-09-30 | $116.37M 10-Q · filed 2014-11-14 |